Keywords: Aquaporin-4 immunoglobulin G-positive; Bayesian network meta-analysis; Eculizumab; Inebilizumab; Matching-adjusted indirect comparison; Neuromyelitis optica spectrum disorder; Randomized controlled trial; Satralizumab.